CarthroniX is a biopharmaceutical company focused on developing small molecule-based therapies for cartilage diseases, including arthritis. Our novel technologies are able to preserve, repair and regenerate cartilage in joints and concurrently suppress inflammation. Our discoveries are based on science conducted by world-class researchers at iconic institutions. We are CarthroniX; we are the future.